EAU 2013 - Programme Book - YouMed

ESU Courses, 17 March
ESU Course 14
12.00 - 14.00 Surgical management of locally advanced and metastatic renal cancer
Green Hall 2 - Level N-1
Chair: M. Kuczyk, Hanover (DE)
State of the art regarding systemic treatment of matastasized renal cancer
S. Osanto, Leiden (NL)
Surgical options for metastasized renal cell cancer
M. Kuczyk, Hanover (DE)
Surgical treatment of locally advanced renal cell cancer
A. Bex, Amsterdam (NL)
Aims and objectives
Although most renal cancers are small and incidentally found, a significant proportion of patients still present
with locally advanced or even metastatic renal cell carcinoma (RCC) at first diagnosis or develop metastatic
spread during the further course of the disease.
RCC is a unique disease where we had important developments in the last 2 decades both in surgical as
well as nonsurgical and systemic therapies. Although we have now at least 7 drugs with proven efficacy in
metastatic RCC, surgery still remains the only curative therapy.
The first aim of this course is to highlight the role of surgery versus a conservative therapeutic approach.
The efficacy of metastasectomy, for example, will be weighed against that of a medical treatment that is
mainly based on anti – VEGF – directed agents. In addition, new therapeutic concepts including neoadjuvant
treatment upfront surgery for locally advanced disease including patients with intracaval thrombosis will be
highlighted.
Surgery for locally advanced disease particularly in patients with vena caval thrombus is a challenging
situation and tips and tricks of this type of surgery including the clinical results that can be achieved by
an aggressive surgical management will be indicated. And finally, the place of cytoreductive nephrectomy
during the treatment of metastatic RCC and the role of surgery for the treatment of locally recurrent disease
will be discussed.
This course is an excellent opportunity to learn what the urologist can offer to renal cancer patients with
difficult tumours and metastatic RCC. The course is an ideal opportunity for all; residents, the practicing
urologist and the oncologic urologist. Don’t miss this course if you see patients with advanced RCC in your
practice!
Registration fee excluding VAT
EAU members € 32
Non-EAU members € 47
Residents (members/non-members) € 21
EAU Milan 2013
337
ESU Courses